• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二抗原刺激将无能 T 细胞转化为 Foxp3 IL-10 调节性 T 细胞。

Conversion of Anergic T Cells Into Foxp3 IL-10 Regulatory T Cells by a Second Antigen Stimulus .

机构信息

Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

出版信息

Front Immunol. 2021 Jun 25;12:704578. doi: 10.3389/fimmu.2021.704578. eCollection 2021.

DOI:10.3389/fimmu.2021.704578
PMID:34249012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8267912/
Abstract

T cell anergy is a common mechanism of T cell tolerance. However, although anergic T cells are retained for longer time periods in their hosts, they remain functionally passive. Here, we describe the induction of anergic CD4 T cells by intravenous application of high doses of antigen and their subsequent conversion into suppressive Foxp3 IL-10 Tr1 cells but not Foxp3 Tregs. We describe the kinetics of up-regulation of several memory-, anergy- and suppression-related markers such as CD44, CD73, FR4, CD25, CD28, PD-1, Egr-2, Foxp3 and CTLA-4 in this process. The conversion into suppressive Tr1 cells correlates with the transient intracellular CTLA-4 expression and required the restimulation of anergic cells in a short-term time window. Restimulation after longer time periods, when CTLA-4 is down-regulated again retains the anergic state but does not lead to the induction of suppressor function. Our data require further functional investigations but at this stage may suggest a role for anergic T cells as a circulating pool of passive cells that may be re-activated into Tr1 cells upon short-term restimulation with high and systemic doses of antigen. It is tentative to speculate that such a scenario may represent cases of allergen responses in non-allergic individuals.

摘要

T 细胞无能是 T 细胞耐受的常见机制。然而,尽管无能的 T 细胞在其宿主中保留更长时间,但它们仍然保持功能上的被动。在这里,我们描述了通过静脉内给予高剂量抗原诱导无能的 CD4 T 细胞及其随后转化为抑制性 Foxp3+IL-10+Tr1 细胞而不是 Foxp3+Tregs。我们描述了在这个过程中几个记忆、无能和抑制相关标记物如 CD44、CD73、FR4、CD25、CD28、PD-1、Egr-2、Foxp3 和 CTLA-4 的上调的动力学。转化为抑制性 Tr1 细胞与细胞内 CTLA-4 表达的瞬时上调相关,并且需要在短时间窗口内对无能细胞进行再刺激。在更长时间后进行再刺激,当 CTLA-4 再次下调时,保持无能状态,但不会导致抑制功能的诱导。我们的数据需要进一步的功能研究,但在现阶段,可能表明无能 T 细胞作为循环池的被动细胞的作用,这些细胞可能在短时间内再次受到高剂量和全身性抗原的刺激后被激活为 Tr1 细胞。可以推测,这种情况可能代表非过敏个体中过敏原反应的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/afd2ebc523fe/fimmu-12-704578-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/1873b064ab8e/fimmu-12-704578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/119bbe225921/fimmu-12-704578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/26e896e6f67e/fimmu-12-704578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/ce2b3fd1187c/fimmu-12-704578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/286fd30d32b7/fimmu-12-704578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/afd2ebc523fe/fimmu-12-704578-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/1873b064ab8e/fimmu-12-704578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/119bbe225921/fimmu-12-704578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/26e896e6f67e/fimmu-12-704578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/ce2b3fd1187c/fimmu-12-704578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/286fd30d32b7/fimmu-12-704578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab47/8267912/afd2ebc523fe/fimmu-12-704578-g006.jpg

相似文献

1
Conversion of Anergic T Cells Into Foxp3 IL-10 Regulatory T Cells by a Second Antigen Stimulus .第二抗原刺激将无能 T 细胞转化为 Foxp3 IL-10 调节性 T 细胞。
Front Immunol. 2021 Jun 25;12:704578. doi: 10.3389/fimmu.2021.704578. eCollection 2021.
2
Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.未成熟树突状细胞通过结合CD28和CTLA-4将无反应性非调节性T细胞转化为Foxp3 - IL-10 +调节性T细胞。
Eur J Immunol. 2015 Feb;45(2):480-91. doi: 10.1002/eji.201444991. Epub 2014 Dec 2.
3
Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.Tr1细胞而非Foxp3 +调节性T细胞通过依赖白细胞介素-10的机制抑制NLRP3炎性小体激活。
J Immunol. 2015 Jul 15;195(2):488-97. doi: 10.4049/jimmunol.1403225. Epub 2015 Jun 8.
4
CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.CD4+ CD25+ [校正后] 调节性T细胞使初始CD4+ CD25- T细胞失能并具有抑制作用。
Immunology. 2007 Apr;120(4):447-55. doi: 10.1111/j.1365-2567.2007.02544.x. Epub 2007 Jan 17.
5
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.由CD25+CD4+天然无反应性和抑制性T细胞维持的免疫自身耐受性:通过打破其无反应性/抑制状态诱导自身免疫性疾病。
Int Immunol. 1998 Dec;10(12):1969-80. doi: 10.1093/intimm/10.12.1969.
6
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.人CD25 + CD4 + T抑制细胞克隆产生转化生长因子β,但不产生白细胞介素10,且不同于1型调节性T细胞。
J Exp Med. 2002 Nov 18;196(10):1335-46. doi: 10.1084/jem.20021139.
7
CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.由白细胞介素-10处理的人树突状细胞诱导产生的CD4(+)和CD8(+)无反应性T细胞表现出抗原特异性抑制活性。
Blood. 2002 Apr 1;99(7):2468-76. doi: 10.1182/blood.v99.7.2468.
8
Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.在转化生长因子-β(TGF-β)存在的情况下,抗原可诱导CD4⁺T细胞受体转基因T细胞中叉头框蛋白P3绿色荧光蛋白阳性(FoxP3gfp⁺)的上调,这些T细胞介导对CD8⁺T细胞应答的连锁抑制。
J Immunol. 2007 Aug 15;179(4):2105-14. doi: 10.4049/jimmunol.179.4.2105.
9
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.胸腺与自身免疫:CD25⁺CD4⁺自然无反应性及抑制性T细胞的产生作为胸腺维持免疫自身耐受的关键功能。
J Immunol. 1999 May 1;162(9):5317-26.
10
Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.外周耐受中的Th3细胞。I. 源自转化生长因子-β T细胞转基因小鼠的Th3细胞诱导Foxp3阳性调节性T细胞
J Immunol. 2007 Jan 1;178(1):179-85. doi: 10.4049/jimmunol.178.1.179.

引用本文的文献

1
Adverse reactions of rush subcutaneous immunotherapy using standardized house dust mite allergen extract and its prediction model construction and analysis.标准化屋尘螨变应原提取物快速皮下免疫治疗的不良反应及其预测模型的构建与分析
Asia Pac Allergy. 2025 Jun;15(2):89-98. doi: 10.5415/apallergy.0000000000000181. Epub 2025 Jun 2.
2
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?细胞内在性CD4 T细胞耐受性:治疗新前沿?
Trends Immunol. 2025 Jul 23. doi: 10.1016/j.it.2025.07.001.
3
Unraveling the complexity of ulcerative colitis: insights into cytokine dysregulation and targeted therapies.

本文引用的文献

1
Regulation of CTLA-4 recycling by LRBA and Rab11.LRBA 和 Rab11 调控 CTLA-4 的循环再利用。
Immunology. 2021 Sep;164(1):106-119. doi: 10.1111/imm.13343. Epub 2021 Jun 6.
2
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.CD86 是一种选择性的 CD28 配体,可在 CTLA-4 水平较高的情况下支持 FoxP3+调节性 T 细胞的稳态。
Front Immunol. 2020 Dec 8;11:600000. doi: 10.3389/fimmu.2020.600000. eCollection 2020.
3
Kinetics and Phenotype of the CD4 T Cell Response to Influenza Virus Infections.
解析溃疡性结肠炎的复杂性:对细胞因子失调和靶向治疗的见解。
EXCLI J. 2025 Jun 6;24:638-658. doi: 10.17179/excli2025-8374. eCollection 2025.
4
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy.一种白细胞介素-2 突变体通过白细胞介素-10 和 CTLA-4 增加调节性 T 细胞对树突状细胞的抑制作用,从而促进 T 细胞无能。
Cell Rep. 2024 Nov 26;43(11):114938. doi: 10.1016/j.celrep.2024.114938. Epub 2024 Nov 2.
5
Discovery and characterization of dietary antigens in oral tolerance.口腔耐受中饮食抗原的发现与表征。
bioRxiv. 2024 May 29:2024.05.26.593976. doi: 10.1101/2024.05.26.593976.
6
An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cells.一种白细胞介素-2突变体可增强调节性T细胞对树突状细胞的白细胞介素-10和细胞毒性T淋巴细胞相关抗原4依赖性抑制作用。
bioRxiv. 2023 Dec 4:2023.12.01.569613. doi: 10.1101/2023.12.01.569613.
7
The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis.变应性鼻炎三种皮下免疫治疗模式的早期转录组及临床疗效分析
World Allergy Organ J. 2023 Sep 6;16(8):100811. doi: 10.1016/j.waojou.2023.100811. eCollection 2023 Aug.
8
Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.调查肌痛性脑脊髓炎/慢性疲劳综合征中 T 细胞和 NK 细胞的代谢和功能障碍特征。
Int J Mol Sci. 2023 Jul 26;24(15):11937. doi: 10.3390/ijms241511937.
9
Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.针对自身免疫性关节炎的基于肽的耐受疫苗靶向抗原特异性 T 细胞的治疗。
Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2218668120. doi: 10.1073/pnas.2218668120. Epub 2023 Jun 12.
10
Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies.口服耐受以预防蛋白质替代疗法中的抗药物抗体形成。
Cell Immunol. 2022 Dec;382:104641. doi: 10.1016/j.cellimm.2022.104641. Epub 2022 Nov 14.
流感病毒感染中 CD4 T 细胞反应的动力学和表型。
Front Immunol. 2019 Oct 2;10:2351. doi: 10.3389/fimmu.2019.02351. eCollection 2019.
4
Relationship between CD4 Regulatory T Cells and Anergy In Vivo.体内CD4调节性T细胞与无反应性之间的关系。
J Immunol. 2017 Apr 1;198(7):2527-2533. doi: 10.4049/jimmunol.1602031.
5
CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors.CD4(+) T细胞失能可预防自身免疫并产生调节性T细胞前体。
Nat Immunol. 2016 Mar;17(3):304-14. doi: 10.1038/ni.3331. Epub 2016 Feb 1.
6
Confusing signals: recent progress in CTLA-4 biology.令人困惑的信号:CTLA-4生物学的最新进展
Trends Immunol. 2015 Feb;36(2):63-70. doi: 10.1016/j.it.2014.12.001. Epub 2015 Jan 9.
7
Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.未成熟树突状细胞通过结合CD28和CTLA-4将无反应性非调节性T细胞转化为Foxp3 - IL-10 +调节性T细胞。
Eur J Immunol. 2015 Feb;45(2):480-91. doi: 10.1002/eji.201444991. Epub 2014 Dec 2.
8
Signals and pathways controlling regulatory T cells.调控性 T 细胞的信号和通路。
Immunol Rev. 2014 Mar;258(1):117-31. doi: 10.1111/imr.12148.
9
Induction and stability of the anergic phenotype in T cells.T 细胞无能表型的诱导和稳定性。
Semin Immunol. 2013 Nov 15;25(4):313-20. doi: 10.1016/j.smim.2013.10.010. Epub 2013 Nov 5.
10
CD39 and CD73 in immunity and inflammation.CD39 和 CD73 在免疫和炎症中的作用。
Trends Mol Med. 2013 Jun;19(6):355-67. doi: 10.1016/j.molmed.2013.03.005. Epub 2013 Apr 17.